Semin Thromb Hemost 2012; 38(06): 622-631
DOI: 10.1055/s-0032-1319767
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

External Quality Assessment of Platelet Disorder Investigations: Results of International Surveys on Diagnostic Tests for Dense Granule Deficiency and Platelet Aggregometry Interpretation

Catherine P.M. Hayward
1   Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
2   Hamilton Regional Laboratory Medicine Program, Special Coagulation Laboratory, Hamilton, Ontario, Canada
,
Karen A. Moffat
2   Hamilton Regional Laboratory Medicine Program, Special Coagulation Laboratory, Hamilton, Ontario, Canada
3   Department of Medicine, McMaster University, Hamilton, Ontario, Canada
,
Elizabeth Plumhoff
4   Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
,
Marnie Timleck
1   Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
,
Suzanne Hoffman
5   University of Wisconsin Hospital and Clinics, UWHC Special Coagulation Laboratory, Madison, Wisconsin
,
Ernie Spitzer
2   Hamilton Regional Laboratory Medicine Program, Special Coagulation Laboratory, Hamilton, Ontario, Canada
,
Elizabeth M. Van Cott
6   Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
,
Piet Meijer
7   ECAT Foundation, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Publication Date:
20 June 2012 (online)

Abstract

The quality of platelet aggregation and dense granule deficiency testing is important for diagnosing platelet function disorders. After a successful pilot exercise on diagnosing platelet dense granule deficiency by electron microscopy (EM), the North American Specialized Coagulation Laboratory Association (NASCOLA) has launched regular external quality assurance (EQA) for dense granule EM, as well as for the interpretation of platelet aggregation findings. EQA records were analyzed to assess performance. For EM EQA, between 2009 and 2011, there was excellent performance in distinguishing normal from dense granule-deficient samples and good (>70%) agreement on classifying most electron dense structures in platelets. For aggregation EQA, some normal variants were misclassified and overall case interpretations were more acceptable for rare disorders than for common findings. NASCOLA experiences with these EQAs indicate that there is a need to improve the quality of platelet disorder evaluations. For aggregometry interpretations, deficits in performance could be addressed by translating guideline recommendations into practice.

 
  • References

  • 1 Hayward CP. Diagnostic evaluation of platelet function disorders. Blood Rev 2011; 25 (4) 169-173
  • 2 Nurden A, Nurden P. Advances in our understanding of the molecular basis of disorders of platelet function. J Thromb Haemost 2011; 9 (Suppl. 01) 76-91
  • 3 Israels SJ. Diagnostic evaluation of platelet function disorders in neonates and children: an update. Semin Thromb Hemost 2009; 35 (2) 181-188
  • 4 Hayward CP, Favaloro EJ. Diagnostic evaluation of platelet disorders: the past, the present, and the future. Semin Thromb Hemost 2009; 35 (2) 127-130
  • 5 Pai M, Hayward CP. Diagnostic assessment of platelet disorders: what are the challenges to standardization?. Semin Thromb Hemost 2009; 35 (2) 131-138
  • 6 Hayward CP, Eikelboom J. Platelet function testing: quality assurance. Semin Thromb Hemost 2007; 33 (3) 273-282
  • 7 Moffat KA, Ledford-Kraemer MR, Nichols WL, Hayward CP ; North American Specialized Coagulation Laboratory Association. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost 2005; 93 (3) 549-553
  • 8 Duncan EM, Bonar R, Rodgers SE, Favaloro EJ, Marsden K ; RCPA QAP in Haematology, Haemostasis Committee. Methodology and outcomes of platelet aggregation testing in Australia, New Zealand and the Asia-Pacific region: results of a survey from the Royal College of Pathologists of Australasia Haematology Quality Assurance Program. Int J Lab Hematol 2009; 31 (4) 398-406
  • 9 Jennings I, Woods TA, Kitchen S, Walker ID. Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006. J Clin Pathol 2008; 61 (8) 950-954
  • 10 Cattaneo M, Hayward CP, Moffat KA, Pugliano MT, Liu Y, Michelson AD. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009; 7 (6) 1029
  • 11 Hayward CP, Pai M, Liu Y , et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost 2009; 7 (4) 676-684
  • 12 Castilloux JF, Moffat KA, Liu Y, Seecharan J, Pai M, Hayward CP. A prospective cohort study of light transmission platelet aggregometry for bleeding disorders: is testing native platelet-rich plasma non-inferior to testing platelet count adjusted samples?. Thromb Haemost 2011; 106 (4) 675-682
  • 13 Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 2009; 35 (2) 158-167
  • 14 Hayward CP, Moffat KA, Raby A , et al. Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry. Am J Clin Pathol 2010; 134 (6) 955-963
  • 15 McGlasson DL, Fritsma GA. Whole blood platelet aggregometry and platelet function testing. Semin Thromb Hemost 2009; 35 (2) 168-180
  • 16 Hayward CP, Moffat KA, Spitzer E , et al; NASCOLA Working Group on Platelet Dense Granule Deficiency. Results of an external proficiency testing exercise on platelet dense-granule deficiency testing by whole mount electron microscopy. Am J Clin Pathol 2009; 131 (5) 671-675
  • 17 Hayward CP, Moffat KA, Plumhoff E, Van Cott EM. Approaches to investigating common bleeding disorders: an evaluation of North American coagulation laboratory practices. Am J Hematol 2012; 87 (Suppl. 01) S45-S50
  • 18 Moffat KA, Ledford-Kraemer MR, Plumhoff EA , et al. Are laboratories following published recommendations for lupus anticoagulant testing? An international evaluation of practices. Thromb Haemost 2009; 101 (1) 178-184
  • 19 Favaloro EJ. Internal quality control and external quality assurance of platelet function tests. Semin Thromb Hemost 2009; 35 (2) 139-149
  • 20 Favaloro EJ, Bonar R. External quality assurance for the PFA-100®. J Thromb Haemost 2011; 9 (4) 878-880
  • 21 Favaloro EJ, Bonar R. Proficiency testing/external quality assurance for the PFA-100 ®. Clin Chem Lab Med 2012; 50: 1393-1401
  • 22 Hayward CP, Moffat KA, Pai M , et al. An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thromb Haemost 2008; 100 (1) 134-145
  • 23 Christie DJ, Avari T, Carrington LR , et al; Clinical and Laboratory Standards Institute (CLSI). Platelet function testing by aggregometry; approved guideline. CLSI document H58-A (ISBN 1–56238–683–2). Wayne, PA: Clinical and Laboratory Standards Institute; 2008; 28 (31) 1-45 . Available at: www.clsi.org . Accessed January 15, 2012
  • 24 Harrison P, Mackie I, Mumford A , et al; British Committee for Standards in Haematology. Guidelines for the laboratory investigation of heritable disorders of platelet function. Br J Haematol 2011; 155 (1) 30-44
  • 25 Pai M, Wang G, Moffat KA , et al. Diagnostic usefulness of a lumi-aggregometer adenosine triphosphate release assay for the assessment of platelet function disorders. Am J Clin Pathol 2011; 136 (3) 350-358
  • 26 Favaloro EJ, Lippi G, Franchini M. Contemporary platelet function testing. Clin Chem Lab Med 2010; 48 (5) 579-598
  • 27 Favaloro EJ, Lippi G. Laboratory reporting of hemostasis assays: the final post-analytical opportunity to reduce errors of clinical diagnosis in hemostasis?. Clin Chem Lab Med 2010; 48 (3) 309-321
  • 28 Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?. Semin Thromb Hemost 2008; 34 (7) 612-634